Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 03, 2025 11:07 ET | Source: Block & Leviton LLP

BREAKING: Block & Leviton Investigating Aldeyra Therapeutics (ALDX) For Securities Fraud After Shares Fall Nearly 75%; Investors Encouraged to Contact the Firm

Shares of Aldeyra Therapeutics are down nearly 75% today. Block & Leviton is investigating ALDX for potential securities fraud. Investors should reach out.